NewMediaWire
Paid press release content from NewMediaWire. The StreetInsider.com news staff was not involved in its creation.
More NewMediaWire
View Older Stories View Newer Stories-
Soulpower Acquisition Corporation Announces the Separate Trading of Its Class A Ordinary Shares and Rights, Commencing May 23, 2025
-
Golden Matrix Group (GMGI) to Participate in the "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow" Presented by Maxim Group LLC on Tuesday, June 3rd - Thursday, June 5th at 9
-
Tim Juliano Joins Peapack Private Bank & Trust
-
Simulated Environment Concepts, Inc. Welcomes Noah Wagler as New Officer to Drive Innovation in Sustainable Agriculture and Seafood Industries
-
GeoVax Applauds EQUIP-A-Pharma Initiative, Reinforces Commitment to Domestic Vaccine Manufacturing and Biodefense Innovation
-
Innovative Designs Projects Over 150% Increase in Fiscal Second Quarter Sales Results vs Previous Year, Continuing Multiple Quarters of Profitability
-
GeoVax Reaffirms Urgent Need for Multi-Antigen COVID-19 Vaccines as CDC Shifts Recommendations
-
BioCorRx Reports Business Update for the First Quarter of 2025
-
Strategic Alliance Between iCoreConnect & HPA Aims to Boost Revenue & Support Independent Dentists & Physicians
-
Assimina "Mina" Nikiforos Joins Peapack Private Bank & Trust
-
QuickLogic to Participate in Ladenburg Thalmann Innovation EXPO25 on May 21, 2025
-
Stephen Reinhardt Joins Peapack Private Bank & Trust
-
ABVC BioPharma Regains Nasdaq Minimum Bid Price Compliance
-
CyberloQ Technologies, Inc. Provides Shareholder Update and Announces Launch of New Marketing Site
-
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504
-
Metavesco's Epic Labor Launches Baltimore Branch, Extending High-Velocity Staffing Network Into Mid-Atlantic Growth Corridor
-
Texas Mineral Resources Announces Appointment of Jonathan Beigle to Board of Directors
-
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for the Quarter Ended March 31, 2025
-
GeoVax Highlights Dual Protective Potential of GEO-CM04S1 Following Presentation at the AAI Annual Meeting 2025
-
GeoVax Expands Gedeptin® Patent Portfolio
-
Forian Inc. to Announce First Quarter 2025 Results on May 14, 2025
-
GeoVax Applauds White House Executive Order Supporting U.S. Pharmaceutical Manufacturing; Highlights Progress in Domestic MVA Vaccine Production
-
GeoVax Reports First Quarter 2025 Financial Results and Provides Business Update
-
AppSwarm Announces Acquisition of AI-Powered "Health Note" Calmi App to Bolster Health and Wellness Application Portfolio
-
United Health Products Announces OTCQB Uplisting and FDA Update
-
ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan
-
Geopulse Exploration, Inc. Completes Acquisition of ATC Services
-
TCRG Announces Formation of Transition Team to Support Upcoming Strategic Transaction
-
GeoVax Presents Gedeptin® Clinical Data at the American Association for Cancer Research Annual Meeting
-
Neutra Corp's Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships
-
CyberloQ Technologies, Inc. Issues Shareholder Update on SOC 2 Compliance, New Patent Filing, 8K Filing With SEC
-
CMUV Bancorp Announces 2025 1st Quarter Financial Results & Notice of Special Shareholder Meeting
-
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry Patent
-
Metavesco Publishes Co-Owners Manual to Shareholders, Setting a New Standard for the OTC Market
-
GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater
-
GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress
-
Peapack Private Bank & Trust Looking Ahead to Long Island
-
VPR Brands, LP Secures Exclusive Distribution Deal With Associated Supply LLC for ELF Brand Expansion Into New York Cannabis Market
-
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen Manufacturing
-
GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025
-
Cavitation Technologies, Inc. Announces the Completion of Cavitation Non-Thermal Plasma System to Address the Global Water Crisis
-
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations
-
Peapack Private Bank & Trust Now Open in NYC
-
Royalty Management Holding Corporation Provides Update on Its Portfolio and Investment Alignment With US Critical Mineral Strategy
-
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
-
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus
-
UPDATE: ABVC BioPharma Announces 2024 Financial Results
-
GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum
-
Quantumzyme Highlights Enzyme Engineering Platform and Ongoing Work in Sustainable Ibuprofen Synthesis
-
ABVC BioPharma Announces 2024 Financial Results

